Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ITGA9 antisense RNA 1 (ITGA9-AS1) is a long non-coding antisense RNA gene located near ITGA9, its sense partner. ITGA9-AS1 is most abundantly found in the cytoplasm of NSCLC cells where it acts by sponging miR-4765, thereby relieving repression of ITGA9 mRNA, and by recruiting RNA-binding protein HNRNPU, which stabilizes ITGA9 mRNA. Functionally, ITGA9-AS1 inhibits cell proliferation and promotes apoptosis in NSCLC models and is downregulated in NSCLC relative to normal tissue, indicating a tumor-suppressive role. It is being investigated as a potential biomarker or therapeutic strategy in cancer, particularly lung carcinoma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ITGA9 antisense RNA 1 (ITGA9-AS1).